Every year, multiple sclerosis researchers and clinicians from around the world meet for the European Congress on Treatments and Research Into Multiple Sclerosis (ECTRIMS) meeting.  In 2019, the conference was held in Stockholm, Sweden between September 11-13.  As always, the Melbourne Brain Centre at the Royal Melbourne Hospital had an incredibly strong presence at the meeting.  This was highlighted through the presentations made, which included around 15 posters and an oral presentation.


It is particularly exciting to have an abstract accepted for an oral presentation at such a prestigious conference, where the competition for these talks is immense.  Considering this, we are incredibly proud of Dr Sifat Sharmin for achieving this honour this year.  Sifat, who is a research fellow in the Clinical Outcomes Research (CORe) Unit here at the Melbourne Brain Centre, submitted her work regarding identifying factors that could predict whether a person living with multiple sclerosis is likely to have good recovery following a relapse.  The presentation, which  (due to Sifat being on maternity leave) was given by A/Prof Tomas Kalincik, was incredibly well-received.


The CORe team was heavily involved, taking the opportunity to showcase all of the fantastic research outcomes that they have generated using MSBase.  MSBase is a large, international database that contains extensive data from people living with multiple sclerosis from 137 clinical centres in 35 countries.  These projects were particularly relevant at this meeting, as the theme of the importance of using observational data, and how it can compliment the information gained from clinical trials, was a key theme throughout the sessions.


Indeed, the title of the headline talk (known as the plenary) was “Beyond randomised controlled trials – why and how observational studies will guide the future of MS treatment”.  It is fantastic to see that our team is very much on the cutting edge of multiple sclerosis research and generating outcomes that will have a major impact on the lives of people living with MS.


Excitingly, our cameras were on hand throughout the 3 day conference to capture interviews with all of our attending researchers.  We will be releasing these videos throughout October, so stay tuned to our website and Facebook page to make sure you don’t miss out!


Click the below banner to learn more about ECTRIMS and stay tuned for our event videos soon.

ECTRIMS 2019 Banner.jpg

By A/Prof Tomas Kalincik

In this video, head of our Clinical Outcomes Research (CORe) Unit, A/Prof Tomas Kalincik, provides an overview of the MBC-RMH's attendance at ECTRIMS 2019 in Stockholm, Sweden.


By Dr Ai-Lan Nguyen

Dr Ai-Lan Nguyen joined us during ECTRIMS 2019 to share her recent work exploring whether pregnancy delays the onset of both clinically isolated syndrome (CIS - a first episode of neurologic symptoms) and multiple sclerosis (MS).


By Dr Charles Malpas

Is it possible to predict whether individuals newly diagnosed with multiple sclerosis are at risk of rapid disease progression? Dr Charles Malpas joined us at ECTRIMS 2019 to explain the work he is doing to answer this question.


By Dr Leighann Henehan

ECTRIMS 2019 provided our neurology trainees with valuable information that is directly transferable to their experiences in the clinic. In this video, Dr Leighann Henehan shares her thoughts on what she learned while in Stockholm, Sweden.


By A/Prof Tomas Kalincik

In this video, A/Prof Tomas Kalincik describes the research undertaken by Dr Sifat Sharmin, that was awarded an oral presentation at ECTRIMS 2019. Dr Sharmin's work will allow clinical trials for multiple sclerosis to provide a clearer idea of the long-term benefits of potential new treatments.